Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA127 for Platelet Recovery in PBSCT
NCT01121120Phase 2Terminated
- Sponsor
- Tarix Pharmaceuticals Ltd.
- Start
- Jun 2010
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of talfirastide in Thrombocytopenia, sponsored by Tarix Pharmaceuticals Ltd.. Started Jun 2010; status: terminated.
02
Drugs
talfirastide
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01121120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121120.